The following generic players have got final/tentative approval to market antimigraine formulation Sumatriptan Succinate 25, 40 and 100 mg tablets (generic version of Imitrex):
Final approvals
1. TEVA (ANDA approved on February 9, 2009)
2. RANBAXY (25 and 50 mg tablets on August 10, 2009; 100 mg on February 9, 2009)
3. DR REDDYS LABS INC (ANDA approved on August 10, 2009)
4. COBALT LABS INC (ANDA approved on August 10, 2009)
5. SANDOZ (ANDA approved on August 10, 2009)
6. ROXANE (ANDA approved on August 10, 2009)
7. ORCHID HLTHCARE (ANDA approved on August 10, 2009)
8. SUN PHARM INDS (ANDA approved on August 10, 2009)
9. AUROBINDO PHARMA (ANDA approved on August 10, 2009)
10. MYLAN (ANDA approved on August 10, 2009)
Tentative approvals
1. GENPHARM (January 24, 2007)
2. WATSON LABS (August 27, 2007)
Most of generic players got final approval on August 10, 2009.
No comments:
Post a Comment